Search Results - ching+wan+ronald+ma

3 Results Sort By:
Bile Acids and Other Agents that Modulate the Gut Microbiome for the Treatment of Liver Cancer
Abstract: Primary liver tumors and secondary hepatic malignancies are among the leading causes of cancer-related deaths. Liver metastases account for 95% of all hepatic cancers, and the liver is the most common site for organ metastasis in the body. The gut microbiome serves an important role in antitumor immunity regulating the efficacy of chemo- and...
Published: 4/8/2024   |   Inventor(s): Tim Greten, Chi Ma
Keywords(s): Bile Acid, Greten, Liver cancer, Natural Killer T Cells, NKT cells
Category(s): Collaboration Sought > Collaboration, TherapeuticArea > Oncology, Application > Therapeutics, Collaboration Sought > Licensing
New Biomarker For Type 2 Diabetes
 
Published: 5/30/2021   |   Inventor(s): Ching Wan Ronald Ma, Wing Yee SO, Chung Ngor Juliana Chan, Hu Cheng, Rong Zhang, Weiping Jia
Keywords(s):  
Category(s): Diagnostics
Use of Multiomic Signature to Predict Diabetes
 
Published: 8/10/2021   |   Inventor(s): Chung Ngor Juliana Chan, Ching Wan Ronald Ma, Heung Man Lee, Xin Liu, Zhibo Gao, Jun Wang
Keywords(s):  
Category(s): Diagnostics